The Second Affiliated Hospital Of Chongqing Medical University
Clinical trials sponsored by The Second Affiliated Hospital Of Chongqing Medical University, explained in plain language.
-
New radiation technique aims to shield healthy lungs, reduce damage
Disease control Recruiting nowThis study is testing a new way to plan radiation therapy for lung cancer. It uses a special scan to map which parts of the lung are healthiest, then aims to steer radiation away from those areas while still treating the tumor. The goal is to reduce lung damage and breathing prob…
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test breakthrough combo to cure hepatitis b
Disease control Recruiting nowThis study is testing a new combination of drugs to try and achieve a 'functional cure' for chronic Hepatitis B, meaning the virus is undetectable and controlled by the immune system without ongoing medication. It will involve 120 adults with Hepatitis B who are already on standa…
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New liver procedure aims to sidestep debilitating brain fog
Disease control Recruiting nowThis study is testing a new way of placing a stent during a common liver procedure called TIPS. The goal is to see if starting with a smaller stent opening can reduce the risk of post-surgery brain complications (hepatic encephalopathy), which often cause confusion and memory pro…
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Breakthrough trial aims to cure hepatitis b with Immune-Boosting combo
Disease control Recruiting nowThis study is testing a new two-drug combination to help people with chronic hepatitis B achieve a 'functional cure,' meaning the virus is controlled long-term without ongoing medication. It combines an immune-boosting antibody with an existing antiviral drug. The trial will enro…
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC